Affiliation
University of Manchester, Manchester, UKIssue Date
2023
Metadata
Show full item recordAbstract
NoneCitation
Lee RJ, Luke JJ. Potential of circulating tumor DNA to refine immunotherapy. Cancer. 2023 Mar 4. PubMed PMID: 36869645. Epub 2023/03/05. eng.Journal
CancerDOI
10.1002/cncr.34714PubMed ID
36869645Additional Links
https://dx.doi.org/10.1002/cncr.34714Type
OtherLanguage
enae974a485f413a2113503eed53cd6c53
10.1002/cncr.34714
Scopus Count
Collections
Related articles
- Circulating Tumor DNA Dynamics: A New Approach in Revolutionizing Cancer Management.
- Authors: Surendran AK, Mavani PT, Vijayakumar C
- Issue date: 2024 Jan
- Use of Circulating Tumor DNA for Cancer Immunotherapy.
- Authors: Snyder A, Morrissey MP, Hellmann MD
- Issue date: 2019 Dec 1
- ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
- Authors: Abbosh C, Swanton C
- Issue date: 2021 Oct
- Circulating Tumor DNA Biomarkers for Early Detection of Oligometastasis.
- Authors: Routman DM, Chera BS, Gupta GP
- Issue date: 2020 Mar/Apr
- Cell-free circulating tumor DNA profiling in cancer management.
- Authors: Roy D, Lucci A, Ignatiadis M, Jeffrey SS
- Issue date: 2021 Oct